Michael Davidson to Pharmacogenetics
This is a "connection" page, showing publications Michael Davidson has written about Pharmacogenetics.
Connection Strength
0.119
-
The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter? Prog Cardiovasc Dis. 2016 Sep - Oct; 59(2):145-152.
Score: 0.094
-
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer. Gut. 2018 10; 67(10):1780-1792.
Score: 0.025